Highlight selection of radiochemistry and radiopharmacy developments by editorial board
-
Published:2024-05-16
Issue:1
Volume:9
Page:
-
ISSN:2365-421X
-
Container-title:EJNMMI Radiopharmacy and Chemistry
-
language:en
-
Short-container-title:EJNMMI radiopharm. chem.
Author:
Toyohara Jun, Vugts Danielle, Kiss Oliver C.ORCID, Todde Sergio, Li Xiang-Guo, Liu Zhibo, Yang Zhi, Gillings Nic, Cazzola Emiliano, Szymanski Wiktor, Meulen Nick van der, Reilly Raymond, Taddei Carlotta, Schirrmacher Ralf, Li Zijing, Lagebo Yohannes Jorge, Bentaleb Naoual, Souza Albernaz Marta de, Lapi Suzanne, Ramogida Caterina, Mukherjee Archana, Ajenjo Javier, Deuther-Conrad Winnie, Bourdeau Cécile
Abstract
Abstract
Background
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Main body
This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.
Conclusion
Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
Funder
Helmholtz-Zentrum Dresden - Rossendorf e.V.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Aghevlian S, Boyle AJ, Reilly RM. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting alpha-particles or Auger electrons. Adv Drug Deliv Rev. 2017;109:102–18. 2. Albertsson P, Bäck T, Bergmark K, Hallqvist A, Johansson M, Aneheim M, Lindegren S, Timperanza C, Smerud K, Palm S. Astatine-211 based radionuclide therapy: current clinical trial landscape. Front Med (Lausanne). 2022;9:1076210. 3. Bauer D, Carter LM, Atmane MI, De Gregorio R, Michel A, Kaminsky S, Monette S, Li M, Schultz MK, Lewis JS. 212Pb-pretargeted theranostics for pancreatic cancer. J Nucl Med. 2024;65:109–16. 4. Blower PJ. A nuclear chocolate box: the periodic table of nuclear medicine. Dalton Trans. 2015;44:4819–44. 5. Bobba KN, Bidkar AP, Meher N, Fong C, Wadhwa A, Dhrona S, Sorlin A, Bidlingmaier S, Shuere B, He J, Wilson DM, Liu B, Seo Y, VanBrocklin HF, Flavell RR. Evaluation of 134Ce/134La as a PET imaging theranostic pair for 225Ac α-Radiotherapeutics. J Nucl Med. 2023;64:1076–82.
|
|